Sell:5.00pBuy:5.50p0.25p
(4.55%)
ANGLE plc is a liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its CTC harvesting technology, known as the Parsortix PC1 System, enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is an in vitro diagnostic device intended to enrich CTCs from peripheral blood collected in K2EDTA tubes from patients diagnosed with metastatic breast cancer. It offers the Portrait+ CTC Staining Kit, which is a ready-to-use laboratory kit for the identification, characterization and enumeration of epithelial and mesenchymal circulating tumor cells, including those undergoing epithelial-to-mesenchymal transition. Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.